Apollo Hospitals Enterprise Ltd reported a consolidated net profit of Rs 502 crore in Q3 FY26, a 35% year-on-year rise, beating analyst estimates. Revenue from operations grew 17% to Rs 6,477 crore, supported by robust healthcare services and Apollo HealthCo. The company also declared an interim dividend of Rs 10 per share.
Apollo Hospitals Enterprise Ltd delivered a strong set of numbers for the December quarter of FY26, surpassing market expectations across revenue, profit, and margins. The performance was driven by organic growth in hospitals, expansion in high-acuity services, and solid momentum in Apollo HealthCo.
Key Highlights
-
Consolidated net profit rose 35% YoY to Rs 502 crore, compared to Rs 372 crore in Q3 FY25
-
Revenue from operations increased 17.2% YoY to Rs 6,477 crore, exceeding estimates of Rs 6,231 crore
-
EBITDA stood at Rs 965 crore, up 26.7% from Rs 762 crore last year, with operating margins expanding to 14.9% from 13.8%
-
Healthcare services revenue grew 14%, while Apollo HealthCo revenue surged 20%, with profits doubling
-
Interim dividend of Rs 10 per equity share announced, record date set as February 16, 2026
-
Strategic plans include adding 1,500 new hospital beds and listing Apollo’s digital health business by FY27
Sources: Moneycontrol, CNBC-TV18, Economic Times, Business Standard